Tamoxifen-elicited uterotrophy: cross-species and cross-ligand analysis of the gene expression program

BACKGROUND: Tamoxifen (TAM) is a well characterized breast cancer drug and selective estrogen receptor modulator (SERM) which also has been associated with a small increase in risk for uterine cancers. TAM's partial agonist activation of estrogen receptor has been characterized for specific gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwekel, Joshua C, Forgacs, Agnes L, Burgoon, Lyle D, Williams, Kurt J, Zacharewski, Timothy R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683873/
https://www.ncbi.nlm.nih.gov/pubmed/19400957
http://dx.doi.org/10.1186/1755-8794-2-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683873/
https://www.ncbi.nlm.nih.gov/pubmed/19400957
http://dx.doi.org/10.1186/1755-8794-2-19

Ejemplares similares